Socinski, M.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

101

Therapeutic advances in non-small cell lung cancer: Highlights from the annual clinical cancer conferences

Corey J. Langer, Mark A. Socinski

Journal:

Community Oncology

Year:

2011

Language:

english

File:

PDF, 527 KB

english, 2011

102

Coexistent breast and vaginal granulocytic sarcoma

Mark A. Socinski, William B. Ershler, Jerome L. Belinson

Journal:

Gynecologic Oncology

Year:

1983

Language:

english

File:

PDF, 2.73 MB

english, 1983

103

A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer

Gillenwater, Heidi H., Stinchcombe, Thomas E., Qaqish, Bahjat F., Tyann, Maureen, Hensing, Thomas A., Socinski, Mark A.

Journal:

Year:

2005

Language:

english

File:

PDF, 140 KB

english, 2005

104

Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer

Hensing, Thomas A., Schell, Michael J., Lee, Ji-Hyun, Socinski, Mark A.

Journal:

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

105

Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status

Stinchcombe, Thomas E., Choi, Jaeun, Schell, Michael J., Mears, Andrea, Jones, Paul E., Nachtsheim, Robert V., Socinski, Mark A.

Journal:

Year:

2006

Language:

english

File:

PDF, 188 KB

english, 2006

106

Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy

Stinchcombe, Thomas E., Morris, David E., Moore, Dominic T., Bechtel, John H., Halle, Jan S., Mears, Andrea, Deschesne, Katherine, Rosenman, Julian G., Socinski, Mark A.

Journal:

Year:

2006

Language:

english

File:

PDF, 164 KB

english, 2006

107

A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer

Stinchcombe, Thomas E., Bůžková, Petra, Choksi, Janak, Taylor, Mark, Bakri, Kamal, Gillenwater, Heidi, Tynan, Maureen, Mears, Andrea, Jones, Paul E., Socinski, Mark A.

Journal:

Year:

2006

Language:

english

File:

PDF, 133 KB

english, 2006

108

Women and lung cancer: Epidemiology, tumor biology, and emerging trends in clinical research

Belani, Chandra P., Marts, Sherry, Schiller, Joan, Socinski, Mark A.

Journal:

Year:

2007

Language:

english

File:

PDF, 178 KB

english, 2007

109

A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer

Treat, Joseph, Edelman, Martin J., Belani, Chandra P., Socinski, Mark A., Monberg, Matthew J., Chen, Ruqin, Obasaju, Coleman K.

Journal:

Year:

2010

Language:

english

File:

PDF, 382 KB

english, 2010

110

A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients

Davies, Janine M., Dhruva, Nirav S., Walko, Christine M., Socinski, Mark A., Bernard, Stephen, Hayes, D. Neil, Kim, William Y., Ivanova, Anastasia, Keller, Kimberly, Hilbun, Layla R., Chiu, Michael, D

Journal:

Year:

2011

Language:

english

File:

PDF, 138 KB

english, 2011

111

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials

Treat, Joseph, Scagliotti, Giorgio V., Peng, Guangbin, Monberg, Matthew J., Obasaju, Coleman K., Socinski, Mark A.

Journal:

Year:

2012

Language:

english

File:

PDF, 783 KB

english, 2012

112

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

Reck, Martin, Thatcher, Nick, Smit, Egbert F., Lorigan, Paul, Szutowicz-Zielinska, Ewa, Liepa, Astra M., Winfree, Katherine B., Peterson, Patrick, Guba, Susan C., Socinski, Mark A.

Journal:

Year:

2012

Language:

english

File:

PDF, 525 KB

english, 2012

113

Results from intermittent and continuous dosing schedules with sunitinib (SU) in previously treated, advanced non–small-cell lung cancer (NSCLC)

G.V. Scagliotti, S. Novello, J.R. Brahmer, R. Rosell, J.M. Sanchez, C.P. Belani, R. Govindan, J.N. Atkins, R.C. Chao, M.A. Socinski

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 90 KB

english, 2008

114

The Role of Induction Therapy for Resectable Non-Small Cell Lung Cancer

Dr Thomas E. Stinchcombe, Mark A. Socinski

Journal:

Year:

2007

Language:

english

File:

PDF, 117 KB

english, 2007

115

Adjuvant Therapy of Resected Non–Small-Cell Lung Cancer

Mark A. Socinski

Journal:

Clinical Lung Cancer

Year:

2004

Language:

english

File:

PDF, 208 KB

english, 2004

116

Second-Line Gemcitabine in Refractory Stage IV Non–Small-Cell Lung Cancer: A Phase II Trial

Heidi H. Gillenwater, Maureen Tynan, Susan Natoli, Michael J. Schell, Mark A. Socinski

Journal:

Clinical Lung Cancer

Year:

2000

Language:

english

File:

PDF, 135 KB

english, 2000

117

Irinotecan in Non–Small-Cell Lung Cancer: Status of Ongoing Trials

Mark A. Socinski

Journal:

Clinical Lung Cancer

Year:

2002

Language:

english

File:

PDF, 138 KB

english, 2002

118

Clinical Issues in the Management of Non–Small-Cell Lung Cancer and the Role of Platinum-Based Therapy

Mark A. Socinski

Journal:

Clinical Lung Cancer

Year:

2004

Language:

english

File:

PDF, 254 KB

english, 2004

119

Current Approaches to Advanced-Stage Non–Small-Cell Lung Cancer: First-Line Therapy in Patients with a Good Functional Status

Thomas E. Stinchcombe, Carrie B. Lee, Mark A. Socinski

Journal:

Clinical Lung Cancer

Year:

2006

Language:

english

File:

PDF, 134 KB

english, 2006

120

Treatment of Surgically Resectable Non–Small-Cell Lung Cancer in Elderly Patients

Benjamin E. Haithcock, Thomas E. Stinchcombe, Mark A. Socinski

Journal:

Clinical Lung Cancer

Year:

2009

Language:

english

File:

PDF, 103 KB

english, 2009

121

Irinotecan (CPT-11) in Triplet Combinations in Patients with Advanced Non–Small-Cell Lung Cancer: A Review and Report of a Phase I/II Trial

Mark A. Socinski, Alan B. Sandler, Langdon L. Miller, Paula K. Locker, Cristy K. Hanover, Gary L. Elfring, Valerie K. Israel, Nicoletta Pirotta, Ronald B. Natale

Journal:

Clinical Lung Cancer

Year:

2001

Language:

english

File:

PDF, 292 KB

english, 2001

122

Therapeutic Advances in Local-Regional Therapy for Stage III Non-Small-Cell Lung Cancer: Evolving Role of Dose-Escalated Conformal (3-Dimensional) Radiation Therapy

Carrie B. Lee, Thomas E. Stinchcombe, Julian G. Rosenman, Mark A. Socinski

Journal:

Clinical Lung Cancer

Year:

2006

Language:

english

File:

PDF, 465 KB

english, 2006

123

Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Jyoti D. Patel, Philip Bonomi, Mark A. Socinski, Ramaswamy Govindan, Shengyan Hong, Coleman Obasaju, Eduardo J. Pennella, Allicia C. Girvan, Susan C. Guba

Journal:

Clinical Lung Cancer

Year:

2009

Language:

english

File:

PDF, 100 KB

english, 2009

124

Safety and efficacy of weekly nab(R)-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer

Socinski, M. A., Langer, C. J., Okamoto, I., Hon, J. K., Hirsh, V., Dakhil, S. R., Page, R. D., Orsini, J., Zhang, H., Renschler, M. F.

Journal:

Annals of Oncology

Year:

2013

Language:

english

File:

PDF, 159 KB

english, 2013

125

The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma

Villaruz, Liza C., Socinski, Mark A., Cunningham, Diana E., Chiosea, Simion I., Burns, Timothy F., Siegfried, Jill M., Dacic, Sanja

Journal:

Year:

2013

Language:

english

File:

PDF, 700 KB

english, 2013

126

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression

Antman, Karen S., Griffin, James D., Elias, Anthony, Socinski, Mark A., Ryan, Louise, Cannistra, Stephen A., Oette, Dagmar, Whitley, Mary, Frei, Emil, Schnipper, Lowell E.

Journal:

Boston Medical and Surgical Journal

Year:

1988

Language:

english

File:

PDF, 1.36 MB

english, 1988

127

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer

Patel, J. D., Socinski, M. A., Garon, E. B., Reynolds, C. H., Spigel, D. R., Olsen, M. R., Hermann, R. C., Jotte, R. M., Beck, T., Richards, D. A., Guba, S. C., Liu, J., Frimodt-Moller, B., John, W. J

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 243 KB

english, 2013

128

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Butts, Charles, Socinski, Mark A, Mitchell, Paul L, Thatcher, Nick, Havel, Libor, Krzakowski, Maciej, Nawrocki, Sergiusz, Ciuleanu, Tudor-Eliade, Bosquée, Lionel, Trigo, José Manuel, Spira, Alexander,

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 546 KB

english, 2014

129

Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutation

Villaruz, Liza C., Socinski, Mark A.

Journal:

Year:

2014

Language:

english

File:

PDF, 397 KB

english, 2014

130

Phase II trial of gemcitabine as second line therapy for non-small cell lung cancer (NSCLC)

Gillenwater, HH, Tynan, M, Socinski, MA

Journal:

Year:

1998

Language:

english

File:

PDF, 129 KB

english, 1998

131

EVIDENCE-BASED MEDICINE IN THE TREATMENT OF NON–SMALL-CELL LUNG CANCER

Reif, Michael S., Socinski, Mark A., Rivera, M. Patricia

Journal:

Clinics in Chest Medicine

Year:

2000

Language:

english

File:

PDF, 1.22 MB

english, 2000

132

P-796 A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC)

Socinski, M., Weissman, C., Hart, L., Beck, J., Choksi, J., Hanson, J., Prager, D., Bloss, L., Ye, Z., Obasaju, C.

Journal:

Year:

2005

Language:

english

File:

PDF, 268 KB

english, 2005

133

P-687 Baseline hemoglobin as a prognostic factor of survival in patients with stage III non-small cell lung cancer

Perry, Michael C., Zhang, Chunfeng, Herndon, James E., Crawford, Jeff, Socinski, Mark, Bogart, Jeff, Green, Mark R.

Journal:

Year:

2003

Language:

english

File:

PDF, 194 KB

english, 2003

134

GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN

Socinski, MarkA., Elias, Anthony, Schnipper, Lowell, Cannistra, StephenA., Antman, KarenH., Griffin, JamesD.

Journal:

Year:

1988

Language:

english

File:

PDF, 739 KB

english, 1988

135

6563 POSTER High-dose 130-nanometer albumin-bound paclitaxel in combination with carboplatin as first-line therapy in advanced non-small cell lung cancer

Hawkins, M.J., Georgy, M., Makhson, A., Cheporov, S., Sergey, O., Yablonsky, P., Bhar, P., Socinski, M.A.

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 78 KB

english, 2007

136

6525 POSTER Phase II study investigating the efficacy and safety of continuous daily sunitinib dosing in previously treated advanced non-small cell lung cancer (NSCLC)

Govindan, R., Brahmer, J.R., Novello, S., Rosell, R., Belani, C.P., Atkins, J.N., Gillenwater, H.H., Tye, L., Chao, R.C., Socinski, M.A.

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 57 KB

english, 2007

137

43 Preoperative chemotherapy in early stage NSCLC: Parallel randomized phase II trials

Detterbeck, Frank C., Socinski, Mark A., Patricia Rivera, M., Edelman, Martin J., Sonett, Joshua R., Raftopoulos, Harry, Gralla, Richard H.

Journal:

Year:

2003

Language:

english

File:

PDF, 188 KB

english, 2003

138

Assessing Response to Treatment in Non–Small-Cell Lung Cancer: Role of Tumor Volume Evaluated By Computed Tomography

Knollmann, Friedrich D., Kumthekar, Rohan, Fetzer, David, Socinski, Mark A.

Journal:

Clinical Lung Cancer

Year:

2014

Language:

english

File:

PDF, 441 KB

english, 2014

139

Erlotinib in African Americans With Advanced Non–Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses

Phelps, M A, Stinchcombe, T E, Blachly, J S, Zhao, W, Schaaf, L J, Starrett, S L, Wei, L, Poi, M, Wang, D, Papp, A, Aimiuwu, J, Gao, Y, Li, J, Otterson, G A, Hicks, W J, Socinski, M A, Villalona-Caler

Journal:

Clinical Pharmacology & Therapeutics

Year:

2014

Language:

english

File:

PDF, 504 KB

english, 2014

140

A single-arm phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology with disease progression on bevacizumab containing therapy

Weiss, Jared M., Villaruz, Liza C., Socinski, Mark A., Ivanova, Anastasia, Grilley-Olson, Juneko, Dhruva, Nirav, Stinchcombe, Thomas E.

Journal:

Year:

2014

Language:

english

File:

PDF, 310 KB

english, 2014

141

A Phase I Trial Defining the Maximum Tolerated Systemic Exposure of Topotecan in Combination with Carboplatin and Etoposide in Extensive Stage Small Cell Lung Cancer

Gillenwater, Heidi H., McCune, Jeannine S., Lindley, Celeste, Faucette, Stephanie, Shord, Stacy, Donahue, Angela, Socinski, Mark A., Stewart, Clinton F., Zamboni, William C., Kirstein, Mark N., Moore,

Journal:

Cancer Investigation

Year:

2005

Language:

english

File:

PDF, 154 KB

english, 2005

142

96-Hour Paclitaxel Infusions: At Least 93 Hours Too Long

O'Neil, Bert H., Socinski, Mark A.

Journal:

Cancer Investigation

Year:

2003

Language:

english

File:

PDF, 57 KB

english, 2003

143

Second-Line Chemotherapy with 96-Hour Infusional Paclitaxel in Refractory Non-Small Cell Lung Cancer: Report of a Phase II Trial

Socinski, Mark A., Steagall, Ann, Gillenwater, Heidi

Journal:

Cancer Investigation

Year:

1999

Language:

english

File:

PDF, 758 KB

english, 1999

144

Switch Maintenance With Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-Controlled Phase 3 Trial

Socinski, M.A., Wang, X., Baggstrom, M., Gu, L., Stinchcombe, T., Edelman, M., Baker, S., Mannuel, H., Crawford, J., Vokes, E.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 130 KB

english, 2014

145

Analysis of Predictive Factors in a Phase 3 Trial of Nab-Paclitaxel (nab-P) Plus Carboplatin (C) as First-Line Therapy for Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC)

Hirsh, V., Page, R.D., Ko, A., Renshler, M., Socinski, M.A.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 57 KB

english, 2014

146

Safety and Efficacy of Necitumumab (N) During Single-Agent Treatment to Progression Following Gemcitabine-Cisplatin (GC) Chemotherapy Plus Necitumumab (IMC-11F8/LY3012211) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (sq-NSCLC) (SQUIRE)

Socinski, M.A., Thatcher, N., Luft, A.V., Szczesna, A., Ciuleanu, T., Szafrański, W., Ramlau, R., Bálint, B., Kazarnowicz, A., Molinier, O., Depenbrock, H., Nanda, S., Obasaju, C., Paz-Ares, L.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 83 KB

english, 2014

147

Enrichment of Met Amplification and Kras Mutations in Non-Small Cell Lung Carcinoma (NSCLC) Brain Metastases

Villaruz, L.C., Socinski, M.A., Derrick, V., Bartoluzzi, S.A., Kurland, B., Nikiforova, M., Burns, T.F., Siegfried, J., Hamilton, R., Dacic, S.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 81 KB

english, 2014

148

Preliminary Results of a Phase 1b Study of Bavituximab (B) Plus Carboplatin (C) and Pemetrexed (P) in Chemotherapy-Naïve Stage IIIb/IV Nonsquamous NSCLC

Grilley-Olson, J.E., Villaruz, L.C., Stinchcombe, T.E., Weiss, J., Lee, C., Shan, J., Ivanova, A., Moore, D.T., Socinski, M.A.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 54 KB

english, 2014

149

Analysis of Outcomes in Diabetic Patients in a Phase 3 Trial of Nab-Paclitaxel (nab-P) Plus Carboplatin (C) in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Hirsh, V., Owen, S.P., Ko, A., Renschler, M., Socinski, M.A.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 58 KB

english, 2014

150

Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)

Gerber, D.E., Socinski, M.A., Neal, J.W., Wakelee, H.A., Shirai, K., Sequist, L.V., Rosovsky, R., Lilenbaum, R., Bastos, B.R., Huang, C., Johnson, M.L., Hasketh, P.J., Subramaniam, D.S., Chai, F., Kaz

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 59 KB

english, 2014